Biliary Tract Diseases

Subscribe to Selected New Research on Biliary Tract Diseases

303 relevant articles (8 outcomes, 20 trials/studies) found for this Disease

Description: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.

Also Known As:

Biliary Tract Disease; Disease, Biliary Tract; Diseases, Biliary Tract; Tract Disease, Biliary; Tract Diseases, Biliary

Relationship Network

Disease Context: Research Results

Digestive System Diseases: 29

Biliary Tract Diseases: 303

Cholelithiasis: 1955

Gallbladder Diseases: 531

Bile Reflux: 252

Biliary Tract Neoplasms: 196

Postcholecystectomy Syndrome: 113

Bile Duct Diseases: 39

Related Diseases

1.	Pain (Aches)
2.	Liver Diseases (Liver Disease)
3.	Pancreatitis
4.	Craniocerebral Trauma (Head Injury)
5.	Colic (Abdominal Cramps)
72 Diseases and 75 more articles analyzed in the Research Interface, order at left...

Experts

1.	Krasinskas, Alyssa M: 1 article (11/2006)
2.	Abraham, Susan C: 1 article (11/2006)
3.	Kamath, Patrick S: 1 article (11/2006)
4.	Eghtesad, Bijan: 1 article (11/2006)
5.	Demetris, Anthony J: 1 article (11/2006)
6.	Shrestha, Roshan: 1 article (04/2006)
7.	Grunkemeier, David M S: 1 article (04/2006)
8.	Huang, Jie-Fu: 1 article (08/2005)
9.	Sang, Xin-Ting: 1 article (08/2005)
10.	Sharfetdinov, Kh Kh: 1 article (01/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Biliary Tract Diseases:

1.	Atropine (Hyoscyamine)FDA LinkGeneric 08/01/1993 - "STUDY OBJECTIVE: To compare the efficacy of IM atropine with placebo for the treatment of pain caused by biliary tract disease" 08/01/1993 - "This study had more than 80% power to detect a 7.5-mm difference in pain relief between atropine and placebo in all patients with biliary tract disease and a 12.5-mm difference in those with biliary colic" Get all the results and reference details, order at left...
2.	lidofenin (HIDA)IBA 01/01/1995 - "As first-line studies to evaluate biliary tract disease, HIDA scans are costly and should be eliminated." Get all the results and reference details, order at left...
3.	Phenobarbital (Luminal)FDA Link 06/01/1977 - "The efficacy of phenobarbital in altering biliary lipid composition in normal man was investigated by determining parameters of biliary lipid metabolism in 8 human subjects without biliary tract disease before and after oral phenobarbital administration at a dose of approximately 3 mg per kg per day for 25 to 54 days" Get all the results and reference details, order at left...
4.	Gentamicins (Gentamicin)FDA LinkGeneric 12/01/1980 - "We studied the efficacy of gentamicin or placebo to decrease the incidence of septic complications after ERCP in 61 inpatients with possible pancreatic or biliary tract disease" Get all the results and reference details, order at left...
5.	Lipase (Acid Lipase)IBA 01/01/1989 - "The aim of this study was to investigate the usefulness of lipase and isoamylases in the diagnosis of acute pancreatitis and to determine if its use permits differential diagnosis between acute pancreatitis and acute biliary tract disease" 07/01/1984 - "The serum lipase response cannot be regarded as specific for pancreatic diseases because the lipase response cases were found in biliary tract diseases as well" 10/16/1971 - "Blood Alpha amylase and lipase activities in surgical biliary tract diseases]" 10/01/2003 - "AIM: Assessing the validity of serum amylase and lipase for the differential diagnosis between acute pancreatitis/acutized chronic pancreatitis, biliary tract disease, perforated gastroduodenal ulcer and acute appendicitis" 01/01/1989 - "In acute biliary tract diseases a high number of elevated enzyme values were also found: pancreatic isoamylase 83.3%, total isoamylase 73.3%, urine amylase 66.6%, lipase 63.3%, serum amylase 53.3%" Get all the results and reference details, order at left...
6.	AntigensIBA 01/01/1995 - "Patients with the liver or biliary tract diseases, symptoms of chronic circulatory insufficiency, Australia (HBs+) antigen carriers and alcoholics were excluded from the research group" 01/01/1997 - "Patients with the liver or biliary tract diseases, chronic circulatory insufficiency symptoms, HBs antigen carriers, who suffered head traumas, CNS illness and heavy drinkers were excluded from the study" 10/01/1990 - "The levels of DU-PAN-2 antigen, carcinoembryonic antigen, and CA19-9 in serum and bile of patients with pancreatic and biliary tract diseases were measured" Get all the results and reference details, order at left...
7.	Cefotiam FDA Link 01/01/1985 - "Basic and clinical studies in 37 patients with biliary tract disease on comparison between cefmenoxime (CMX) and cefotiam (CTM) were studied and the following results were obtained" 05/01/1986 - "To test the effectiveness of cefmenoxime (CMX) and cefotiam (CTM) in patients with biliary tract diseases, concentrations of either antibiotic were measured after an intravenous bolus injection of 1.0 g of CMX or CTM, or simultaneous injection of both (1.0 g each)" 05/01/1986 - "Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases]" Get all the results and reference details, order at left...
8.	Cefmenoxime (Cefmax)FDA Link 01/01/1985 - "Basic and clinical studies in 37 patients with biliary tract disease on comparison between cefmenoxime (CMX) and cefotiam (CTM) were studied and the following results were obtained" 05/01/1986 - "To test the effectiveness of cefmenoxime (CMX) and cefotiam (CTM) in patients with biliary tract diseases, concentrations of either antibiotic were measured after an intravenous bolus injection of 1.0 g of CMX or CTM, or simultaneous injection of both (1.0 g each)" 05/01/1986 - "Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases]" Get all the results and reference details, order at left...
9.	Messenger RNA (mRNA)IBA 01/01/2007 - "CONCLUSIONS: The combination of cytological examination and hTERT mRNA analysis appeared useful for the preoperative diagnosis of malignant biliary tract diseases, but was not superior to diagnostic imaging studies, and therefore remains an adjunct to cytological examination" 07/14/2006 - "RESULTS: hTERT mRNA was detected in 28 of 33 (84.85%) of serum obtained from cholangiocarcinoma patients and 9 of 41 (21.9%) of serum obtained from benign biliary tract disease patients" 07/14/2006 - "METHODS: The serum of thirty three cholangiocarcinoma patients, forty one benign biliary tract disease patients and ten healthy volunteers were collected and analyzed for the expression of hTERT mRNA by real-time reverse transcriptase-polymerase chain reaction (RT-PCR)" Get all the results and reference details, order at left...
10.	Factor IX (PTC)FDA LinkGeneric 08/01/2007 - "BACKGROUND AND STUDY AIMS: Percutaneous transhepatic cholangioscopy (PTC) is being increasingly used for patients with biliary tract diseases" 08/01/2007 - "CONCLUSIONS: PTC is a relatively safe and well-tolerated method for treating certain biliary tract diseases" 02/01/1978 - "Fine-needle percutaneous transhepatic cholangiography (PTC) was performed in a series of 46 patients with jaundice or suspected biliary tract disease" Get all the results and reference details, order at left...
157 Drugs and Important Bio-Agents and 192 more articles analyzed in the Research Interface, order at left...

Therapies and Procedures

1.	Laparoscopic Cholecystectomy 01/01/2008 - "CONCLUSIONS: Laparoscopic cholecystectomy is superior to nonoperative management for pregnant women presenting in the first or second trimester with biliary tract disease." 11/01/1992 - "Laparoscopic cholecystectomy appears to be a safe treatment for selected patients with symptomatic biliary tract disease during pregnancy" 01/01/2008 - "METHODS: We constructed a Markov decision analytic model that incorporates maternal well-being and fetal outcome into a choice between nonoperative management (NM) and laparoscopic cholecystectomy (LC) for pregnant women with biliary tract disease (BTD)" 11/01/2001 - "INTRODUCTION: At first, laparoscopic cholecystectomy was considered unsuitable for patients presenting biliary tract diseases" 07/01/2001 - "Laparoscopic cholecystectomy is the procedure of choice in the elective management of biliary tract disease in the octogenarian" Get all the results and reference details, order at left...
2.	Choledochostomy 01/01/1986 - "Our results suggest that choledochoduodenostomy is a safe and effective procedure in the management of calculous biliary tract disease for old patients." 02/01/1992 - "Between 1986 and 1991, 16 selected patients with calculous biliary tract disease (CBTD) underwent side-to-side choledochoduodenostomy (CDS) as an adjunct to either primary (10 patients) or secondary (six patients) choledocholithotomy" 02/01/1992 - "Adjunctive choledochoduodenostomy to choledocholithotomy in the treatment of calculous biliary tract disease." 08/01/1990 - "Primary choledochoduodenostomy for benign obstructive biliary tract disease." 06/01/1989 - "Indications and results of choledochoduodenostomy in benign biliary tract diseases." Get all the results and reference details, order at left...
3.	Liver Transplantation 11/01/2006 - "Chronic biliary tract disease is the third most common indication for orthotopic liver transplantation (OLT) in the United States" 04/01/2006 - "Endoscopic treatment of biliary tract disease prior to orthotopic liver transplantation." 08/01/2005 - "Biliary tract diseases have always been one of the important indications for liver transplantation" 08/01/2005 - "Liver transplantation for biliary tract disease]" 01/01/2001 - "Endoscopic therapy for biliary tract disease before orthotopic liver transplantation." Get all the results and reference details, order at left...
4.	Cholecystectomy 05/01/1998 - "The purpose of this study is to evaluate the utility of quantitative cholescintigraphy in detecting symptomatic biliary tract disease and predicting clinical relief after cholecystectomy" 10/01/2003 - "CONCLUSION: Modified cholescintigraphy is a useful test for predicting which patients with acalculous biliary tract disease benefit from a cholecystectomy." 07/01/2001 - "We retrospectively reviewed 70 patients who were 80 years of age and older who underwent cholecystectomy at our institution for biliary tract disease" 04/01/2001 - "Today, adverse outcomes after open cholecystectomy are limited to the elderly patients with comorbid conditions and complicated biliary tract disease" 09/01/1995 - "BACKGROUND: Recurrent common bile duct (CBD) stones after cholecystectomy are a common biliary tract disease" Get all the results and reference details, order at left...
5.	Transplantation (Transplant Recipients) 10/01/1995 - "BACKGROUND AND STUDY AIMS: Diagnostic imaging of the biliary tract is often required in liver transplant recipients, preoperatively to assess extent of biliary tract disease and postoperatively in patients with a suspected biliary complication due to an abnormal postoperative course" 04/01/1998 - "BACKGROUND: Biliary tract diseases are frequent in heart transplant recipients, with significant morbidity and mortality" 09/01/1989 - "Significance of asymptomatic biliary tract disease in heart transplant recipients." 04/01/2005 - "PATIENTS: Cardiac transplant recipients between January 1, 1992, and January 1, 2001.Main Outcome Measure Clinical course of patients who were diagnosed as having biliary tract disease following heart transplantation and were managed expectantly (observed) compared with the course of patients whose conditions were diagnosed and who underwent an operation" Get all the results and reference details, order at left...
39 Therapies and Procedures and 119 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>